Gastric expression of inducible nitric oxide synthase and myeloperoxidase in relation to nitrotyrosine in Helicobacter pylori-infected Mongolian gerbils

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 9, 2006, Pages 1013-1018

  Elfvin, Anders ^a   Bölin, Ingrid ^a   Lönroth, Hans ^a   Fändriks, Lars ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Animal model; Helicobacter pylori; infection; Mongolian gerbil; mucosa; stomach

Indexed keywords

3 NITROTYROSINE; 3-NITROTYROSINE; DRUG DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXIDASE; TYROSINE;

ANIMAL; ARTICLE; BIOSYNTHESIS; DISEASE MODEL; GERBIL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOSPITALIZATION; MALE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PYLORUS; RAT; STOMACH ANTRUM; STOMACH MUCOSA; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; GASTRIC MUCOSA; GERBILLINAE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MALE; NITRIC OXIDE SYNTHASE TYPE II; PEROXIDASE; PYLORIC ANTRUM; PYLORUS; RATS; SEVERITY OF ILLNESS INDEX; TYROSINE;

EID: 35148889000     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600633537     Document Type: Article

References (25)

1. Sipponen P, Kosunen TU, Valle J, Riihela M, Seppala K. Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 1992; 45: 319–23
2. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127–31
3. Tummala S, Keates S, Kelly CP. Update on the immunologic basis of Helicobacter pylori gastritis. Curr Opin Gastroenterol 2004; 20: 592–7
4. Bentz BG, Simmons RL, Haines GK, III, Radosevich JA. The yin and yang of nitric oxide: reflections on the physiology and pathophysiology of NO. Head Neck 2000; 22: 71–83
5. Jaiswal M, LaRusso NF, Gores GJ. Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol 2001; 281: G626–34
6. Iguchi M, Shiotani A, Nishioka S. Helicobacter pylori infection reduces intraluminal nitric oxide. Scand J Gastroenterol 2000; 35: 694–8
7. von Bothmer C, Edebo A, Lonroth H, Olbe L, Pettersson A, Fandriks L. Helicobacter pylori infection inhibits antral mucosal nitric oxide production in humans. Scand J Gastroenterol 2002; 37: 404–8
8. von Bothmer C, Bolin I, Pettersson A, Fandriks L. Stimulated murine macrophages as a bioassay for H. pylori-related inhibition of nitric oxide production. Scand J Gastroenterol 2003; 38: 380–6
9. Elfvin A, Bölin I, von Bothmer C, Stolte M, Watanabe H, Fandriks L, et al. Helicobacter pylori induces gastritis and intestinal metaplasia but no gastric adenocarcinoma in Mongolian gerbils. Scand J Gastroenterol 2005; 40: 1313–20
10. Sun Y-Q, Petersson F, Monstein H-J, Söderholm JD, Rehfeld JF, Borch K. Long-term morpho-functional develoment of Helicobacter pylori-induced gastritis in Mongolian gerbils. Scand J Gastroenterol 2005; 40: 1157–67
11. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998; 115: 642–8
12. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997; 112: 1386–97
13. Crabtree JE, Court M, Aboshkiwa MA, Jeremy AH, Dixon MF, Robinson PA. Gastric mucosal cytokine and epithelial cell responses to Helicobacter pylori infection in Mongolian gerbils. J Pathol 2004; 202: 197–207
14. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–54
15. Ikeno T, Ota H, Sugiyama A, Ishida K, Katsuyama T, Genta RM, et al. Helicobacter pylori-induced chronic active gastritis, intestinal metaplasia, and gastric ulcer in Mongolian gerbils. Am J Pathol 1999; 154: 951–60
16. Bergin IL, Sheppard BJ, Fox JG. Helicobacter pylori infection and high dietary salt independently induce atrophic gastritis and intestinal metaplasia in commercially available outbred Mongolian gerbils. Dig Dis Sci 2003; 48: 475–85
17. Keto Y, Ebata M, Okabe S. Gastric mucosal changes induced by long-term infection with Helicobacter pylori in Mongolian gerbils: effects of bacteria eradication. J Physiol Paris 2001; 95: 429–36
18. Sugiyama T, Hige S, Asaka M. Development of an H. pylori-infected animal model and gastric cancer: recent progress and issues. J Gastroenterol 2002; 37 Suppl 13: 6–9
19. Li CQ, Pignatelli B, Ohshima H. Coexpression of interleukin-8 and inducible nitric oxide synthase in gastric mucosa infected with cagA+ Helicobacter pylori. Dig Dis Sci 2000; 45: 55–62
20. Brzozowski T, Konturek PC, Sliwowski Z, Drozdowicz D, Pajdo R, Stachura J, et al. Lipopolysaccharide of Helicobacter pylori protects gastric mucosa via generation of nitric oxide. J Physiol Pharmacol 1997; 48: 699–717
21. Franco L, Talamini G, Carra G, Doria D. Expression of COX-1, COX-2, and inducible nitric oxide synthase protein in human gastric antrum with Helicobacter pylori infection. Prostaglandins Other Lipid Mediat 1999; 58: 9–17
22. Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, et al. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 1999; 116: 1319–29
23. Konturek PC, Brzozowski T, Sliwowski Z, Pajdo R, Stachura J, Hahn EG, et al. Involvement of nitric oxide and prostaglandins in gastroprotection induced by bacterial lipopolysaccharide. Scand J Gastroenterol 1998; 33: 691–700
24. Sakaguchi AA, Miura S, Takeuchi T, Hokari R, Mizumori M, Yoshida H, et al. Increased expression of inducible nitric oxide synthase and peroxynitrite in Helicobacter pylori gastric ulcer. Free Radic Biol Med 19919; 27: 781–9
25. Goto T, Haruma K, Kitadai Y, Ito M, Yoshihara M, Sumii K, et al. Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients. Clin Cancer Res 1999; 5: 1411–5